Pulmozyme 1 MG/ML ampul 2.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9KJ6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $118,562
Award facts
- Contract value 100% obligated
- $118,562.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $118,562.07 to AmerisourceBergen Drug Corp for the supply of Pulmozyme 1 mg/ml ampule 2.5ml, a pharmaceutical product used in the treatment of cystic fibrosis. The contract is a firm fixed-price delivery order with an ultimate completion date of January 12, 2026, and was awarded on January 9, 2026. This award was made on a non-set-aside, competitive basis to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, which is the place of performance for this contract. The company operates as a subsidiary of Cencora, Inc., formerly known as AmerisourceBergen.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with the DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. The IDC enables the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare systems globally, including medications, vaccines, syringes, and specialized medical commodities across multiple therapeutic domains. AmerisourceBergen's federal contract portfolio demonstrates its critical role in supplying essential medications and healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9KJ6?
SPE2DR26F9KJ6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F9KJ6 worth?
The government has obligated $118,562 on SPE2DR26F9KJ6.
Is contract SPE2DR26F9KJ6 an order under another contract?
Yes. SPE2DR26F9KJ6 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KJ6 competed?
The extent of competition for SPE2DR26F9KJ6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award